Dr. Gloria González-Aseguinolaza, Vivet Therapeutics CSO & Head of the Gene Therapy
Anne Douar, Chief Development Officer of Vivet Therapeutics, will give a presentation ("Manufacturing of a New Gene Therapy Product: Long…
Jean-Philippe Combal, Vivet Therapeutics' CEO, will be hosting 1x1 meetings during Chardan 's 3rd Annual Genetic Medicines Conference, Oct 7-8,…
Vivet Therapeutics CEO, Jean-Philippe Combal, will be giving a corporate presentation during 2019 Cell & Gene Meeting on the Mesa in Carlsbad on…
Jean-Philippe Combal, Vivet Therapeutics' CEO
Vivet's CEO, Jean-Philippe Combal and Thomas Daniel, BD Director, will be hosting 1x1 meetings during BIO 2019 in Philadelphia on June 3-6.
Jean-Philippe Combal, Vivet CEO, will be attending a panel
Paris, France, April 24, 2019 – Vivet Therapeutics (“Vivet”), a privately held gene therapy biotech company dedicated to developing gene therapy treatments
Vivet Therapeutics will be making a presentation on its lead product